Cargando…

Residual Expression of the Reprogramming Factors Prevents Differentiation of iPSC Generated from Human Fibroblasts and Cord Blood CD34+ Progenitors

Human induced pluripotent stem cells (hiPSC) have been generated from different tissues, with the age of the donor, tissue source and specific cell type influencing the reprogramming process. Reprogramming hematopoietic progenitors to hiPSC may provide a very useful cellular system for modelling blo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramos-Mejía, Verónica, Montes, Rosa, Bueno, Clara, Ayllón, Verónica, Real, Pedro J., Rodríguez, René, Menendez, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335819/ https://www.ncbi.nlm.nih.gov/pubmed/22545141 http://dx.doi.org/10.1371/journal.pone.0035824

Ejemplares similares

Understanding the Molecular Basis of iPSC Reprogrammed Cells to Fulfil Their Expectations in Future Clinical Applications
por: González-Fernández, Verónica, et al.
Publicado: (2022)

Assessment of safety and immunogenicity of MHC homozygous iPSC-derived CD34(+) hematopoietic progenitors in an NHP model
por: D’Souza, Saritha S., et al.
Publicado: (2022)

Liver cell reprogramming: Parallels with iPSC biology
por: Yanger, Kilangsungla, et al.
Publicado: (2014)

Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming
por: Hu, Kejin
Publicado: (2020)

Gender Differences in Global but Not Targeted Demethylation in iPSC Reprogramming
por: Milagre, Inês, et al.
Publicado: (2017)

Extensive reprogramming of the nascent transcriptome during iPSC to hepatocyte differentiation
por: Viiri, Leena E., et al.
Publicado: (2019)

OVOL1 Influences the Determination and Expansion of iPSC Reprogramming Intermediates
por: Kagawa, Harunobu, et al.
Publicado: (2019)

iPSC reprogramming-mediated aneuploidy correction in autosomal trisomy syndromes
por: Akutsu, Silvia Natsuko, et al.
Publicado: (2022)

Attenuating iPSC reprogramming stress with dominant-negative BET peptides
por: Hossain, Md Emon, et al.
Publicado: (2022)

Gammaretroviral vector encoding a fluorescent marker to facilitate detection of reprogrammed human fibroblasts during iPSC generation
por: Srinivasakumar, Narasimhachar, et al.
Publicado: (2013)

Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors
por: Varderidou-Minasian, Suzy, et al.
Publicado: (2020)

Automated high-content imaging in iPSC-derived neuronal progenitors
por: Papandreou, Apostolos, et al.
Publicado: (2023)

Fine-Tuning of iPSC Derivation by an Inducible Reprogramming System at the Protein Level
por: Sui, Dandan, et al.
Publicado: (2014)

Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming
por: Janiszewski, Adrian, et al.
Publicado: (2019)

Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells
por: Kajikawa, Keita, et al.
Publicado: (2020)

Direct Reprogramming Rather than iPSC-Based Reprogramming Maintains Aging Hallmarks in Human Motor Neurons
por: Tang, Yu, et al.
Publicado: (2017)

Comparison of reprogramming factor targets reveals both species-specific and conserved mechanisms in early iPSC reprogramming
por: Fu, Kai, et al.
Publicado: (2018)

Inducible Expression of GDNF in Transplanted iPSC-Derived Neural Progenitor Cells
por: Akhtar, Aslam Abbasi, et al.
Publicado: (2018)

Transient Acquisition of Pluripotency During Somatic Cell Transdifferentiation with iPSC Reprogramming Factors
por: Maza, Itay, et al.
Publicado: (2015)

Regenerative therapy for spinal cord injury using iPSC technology
por: Nagoshi, Narihito, et al.
Publicado: (2020)

Growth Factor-Activated Stem Cell Circuits and Stromal Signals Cooperatively Accelerate Non-Integrated iPSC Reprogramming of Human Myeloid Progenitors
por: Park, Tea Soon, et al.
Publicado: (2012)

A PIANO (Proper, Insufficient, Aberrant, and NO Reprogramming) Response to the Yamanaka Factors in the Initial Stages of Human iPSC Reprogramming
por: Hu, Kejin
Publicado: (2020)

MicroRNAs promote skeletal muscle differentiation of mesodermal iPSC-derived progenitors
por: Giacomazzi, Giorgia, et al.
Publicado: (2017)

Cellular reprogramming in farm animals: an overview of iPSC generation in the mammalian farm animal species
por: Ogorevc, J., et al.
Publicado: (2016)

Naked Mole Rat Cells Have a Stable Epigenome that Resists iPSC Reprogramming
por: Tan, Li, et al.
Publicado: (2017)

Macrophages Modulate the Function of MSC- and iPSC-Derived Fibroblasts in the Presence of Polyethylene Particles
por: Gao, Qi, et al.
Publicado: (2021)

Human iPSC-derived neural progenitor cells secreting GDNF provide protection in rodent models of ALS and retinal degeneration
por: Laperle, Alexander H., et al.
Publicado: (2023)

Activin Is Superior to BMP7 for Efficient Maintenance of Human iPSC-Derived Nephron Progenitors
por: Tanigawa, Shunsuke, et al.
Publicado: (2019)

Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease
por: Hiller, Benjamin M., et al.
Publicado: (2022)

Mesenchymal properties of iPSC-derived neural progenitors that generate undesired grafts after transplantation
por: Isoda, Miho, et al.
Publicado: (2023)

Improvement in Mouse iPSC Induction by Rab32 Reveals the Importance of Lipid Metabolism during Reprogramming
por: Pei, Yangli, et al.
Publicado: (2015)

Concurrent progress of reprogramming and gene correction to overcome therapeutic limitation of mutant ALK2-iPSC
por: Kim, Bu-Yeo, et al.
Publicado: (2016)

Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing
por: Tidball, Andrew M., et al.
Publicado: (2017)

Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming
por: Generoso, Serena F., et al.
Publicado: (2023)

Rehabilitative Training Enhances Therapeutic Effect of Human iPSC-Derived Neural Stem/Progenitor Cells Transplantation in Chronic Spinal Cord Injury
por: Shibata, Takahiro, et al.
Publicado: (2023)

Banking on iPSC- Is it Doable and is it Worthwhile
por: Solomon, Susan, et al.
Publicado: (2014)

Roadblocks in the Path of iPSC to the Clinic
por: Garreta, Elena, et al.
Publicado: (2018)

iPSC Bioprinting: Where are We at?
por: Romanazzo, Sara, et al.
Publicado: (2019)

Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020)

iPSC for modeling neurodegenerative disorders
por: Valadez-Barba, Valeria, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_md95mgsfvbu4s5svmne2dsabu7